HOPKINTON, Mass., Nov. 6 -- Facet Solutions, Inc. announced today that it has acquired all of the assets of Archus Orthopedics.The acquisition creates an undisputed leadership position in product offerings, intellectual property and clinical experience in posterior motion preservation. "This is a win for patients suffering from lumbar spinal stenosis," stated Facet Solutions'
With the Archus acquisition, Facet Solutions now holds 36 patents and nearly 200 patent applications. "The combined portfolio represents an unprecedented level of coverage for an orthopedic product category," stated Marc Peterman, Vice President of Research & Development for Facet Solutions. "The acquisition clarifies Facet Solutions' intellectual property position and provides a tremendous platform for innovation. Our posterior motion solutions hold the potential to supplant the bulk of the degenerative fusion market."
Facet Solutions is currently enrolling the ACADIA™ lumbar stenosis study. "We are making rapid progress in our US Pivotal trial," continued Geoff Pardo. "The speed with which we are enrolling patients is indicative of both the market need and the simplicity of the ACADIA™ procedure." Twenty sites in the United States are now active in the trial, with over 100 patients enrolled in 2009. The combined company has treated over 300 patients worldwide, with excellent clinical outcomes extending past 4 years.
About Lumbar Stenosis
Over 1.5 million people are diagnosed with lumbar spinal stenosis each year in the United States. There are 400,000 surgeries annually in the United States targeting lumbar spinal stenosis. Facet Solutions has developed the ACADIA™ system, offering the potential of quicker recovery, restoration of range of motion, and better overall pain relief for the patient suffering from both leg and back pain.
About Facet Solutions
Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of degenerative spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Spray Venture Partners, and FirstMark Capital. Facet Solutions is certified to ISO 13485. ACADIA™ is an investigational device in the United States (U.S.), limited by Federal Law for investigational use only.
SOURCE Facet Solutions, Inc.
Subscribe to our Free Newsletters!
Reflux nephropathy is the scarring and damage caused to the kidneys by reverse flow of urine from ...
Drug abuse is a negative social trend that pushes youth to drug addiction in the pretext of getting ...
Proper understanding of waste collection, segregation and management is required to reduce the ...View All